Publications
Detailed Information
Therapeutic efficacy of ABN401, highly selective c-MET inhibitor, in NSCLC with MET-amplified AND/OR EGFR mutation
Cited 0 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Issue Date
- 2019-07
- Publisher
- American Association for Cancer Research
- Citation
- Cancer Research, Vol.79 No.13
- ISSN
- 0008-5472
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.